841 related articles for article (PubMed ID: 28575312)
21. Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.
Kes MMG; Van den Bossche J; Griffioen AW; Huijbers EJM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188427. PubMed ID: 32961257
[TBL] [Abstract][Full Text] [Related]
22. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of the glioma microenvironment].
Herrlinger U; Platten M
Nervenarzt; 2015 Jun; 86(6):684, 686-8, 690-1. PubMed ID: 25962344
[TBL] [Abstract][Full Text] [Related]
24. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
Lin L; Chen YS; Yao YD; Chen JQ; Chen JN; Huang SY; Zeng YJ; Yao HR; Zeng SH; Fu YS; Song EW
Oncotarget; 2015 Oct; 6(33):34758-73. PubMed ID: 26416449
[TBL] [Abstract][Full Text] [Related]
25. New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy.
Guo Q; Jin Z; Yuan Y; Liu R; Xu T; Wei H; Xu X; He S; Chen S; Shi Z; Hou W; Hua B
J Immunol Res; 2016; 2016():9720912. PubMed ID: 27975071
[TBL] [Abstract][Full Text] [Related]
26. Targeting tumor-associated macrophages as an antitumor strategy.
Cheng N; Bai X; Shu Y; Ahmad O; Shen P
Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
[TBL] [Abstract][Full Text] [Related]
27. Role of tumor-associated macrophages in human malignancies: friend or foe?
Takeya M; Komohara Y
Pathol Int; 2016 Sep; 66(9):491-505. PubMed ID: 27444136
[TBL] [Abstract][Full Text] [Related]
28. Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer.
Lao L; Fan S; Song E
Adv Exp Med Biol; 2017; 1026():331-370. PubMed ID: 29282692
[TBL] [Abstract][Full Text] [Related]
29. Phagocytes as Corrupted Policemen in Cancer-Related Inflammation.
Bonavita E; Galdiero MR; Jaillon S; Mantovani A
Adv Cancer Res; 2015; 128():141-71. PubMed ID: 26216632
[TBL] [Abstract][Full Text] [Related]
30. Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor-Glioma Therapy?
Tong N; He Z; Ma Y; Wang Z; Huang Z; Cao H; Xu L; Zou Y; Wang W; Yi C; Yin Z; Wang Q
Front Cell Dev Biol; 2021; 9():706286. PubMed ID: 34368156
[TBL] [Abstract][Full Text] [Related]
31. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
Gao J; Liang Y; Wang L
Front Immunol; 2022; 13():888713. PubMed ID: 35844605
[TBL] [Abstract][Full Text] [Related]
32. Macrophages in multiple myeloma.
Ribatti D; Moschetta M; Vacca A
Immunol Lett; 2014 Oct; 161(2):241-4. PubMed ID: 24370642
[TBL] [Abstract][Full Text] [Related]
33. Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review).
Su P; Li O; Ke K; Jiang Z; Wu J; Wang Y; Mou Y; Jin W
Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38695252
[TBL] [Abstract][Full Text] [Related]
34. Harnessing tumor-associated macrophages as aids for cancer immunotherapy.
Li X; Liu R; Su X; Pan Y; Han X; Shao C; Shi Y
Mol Cancer; 2019 Dec; 18(1):177. PubMed ID: 31805946
[TBL] [Abstract][Full Text] [Related]
35. Tumor-associated macrophages in thoracic malignancies.
Lievense LA; Bezemer K; Aerts JG; Hegmans JP
Lung Cancer; 2013 Jun; 80(3):256-62. PubMed ID: 23489559
[TBL] [Abstract][Full Text] [Related]
36. Tumor suppressor ARF regulates tissue microenvironment and tumor growth through modulation of macrophage polarization.
Jiménez-García L; Herranz S; Higueras MA; Luque A; Hortelano S
Oncotarget; 2016 Oct; 7(41):66835-66850. PubMed ID: 27572316
[TBL] [Abstract][Full Text] [Related]
37. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.
Zheng X; Turkowski K; Mora J; Brüne B; Seeger W; Weigert A; Savai R
Oncotarget; 2017 Jul; 8(29):48436-48452. PubMed ID: 28467800
[TBL] [Abstract][Full Text] [Related]
38. Targeting Options of Tumor-Associated Macrophages (TAM) Activity in Gliomas.
Anagnostakis F; Piperi C
Curr Neuropharmacol; 2023; 21(3):457-470. PubMed ID: 35048810
[TBL] [Abstract][Full Text] [Related]
39. CYP4X1 Inhibition by Flavonoid CH625 Normalizes Glioma Vasculature through Reprogramming TAMs via CB2 and EGFR-STAT3 Axis.
Wang C; Li Y; Chen H; Huang K; Liu X; Qiu M; Liu Y; Yang Y; Yang J
J Pharmacol Exp Ther; 2018 Apr; 365(1):72-83. PubMed ID: 29437915
[TBL] [Abstract][Full Text] [Related]
40. Tumor-Associated Macrophages as Target for Antitumor Therapy.
Sawa-Wejksza K; Kandefer-Szerszeń M
Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):97-111. PubMed ID: 28660349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
